A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection

8.4K views

⸱

DOI:

10.3791/60599

⸱

February 20th, 2020

 ,  ,  ,  ,  ,  ,  , 

* These authors contributed equally

In This Article

Summary

We describe a delayed inoculation protocol for generating chronic wound infections in immunocompetent mice.

Abstract

Pseudomonas aeruginosa (P. aeruginosa) is a major nosocomial pathogen of increasing relevance to human health and disease, particularly in the setting of chronic wound infections in diabetic and hospitalized patients. There is an urgent need for chronic infection models to aid in the investigation of wound pathogenesis and the development of new therapies against this pathogen. Here, we describe a protocol that uses delayed inoculation 24 hours after full-thickness excisional wounding. The infection of the provisional wound matrix present at this time forestalls either rapid clearance or dissemination of infection and instead establishes chronic infection lasting 7–10 days without the need for implantation of foreign materials or immune suppression. This protocol mimics a typical temporal course of post-operative infection in humans. The use of a luminescent P. aeruginosa strain (PAO1:lux) allows for quantitative daily assessment of bacterial burden for P. aeruginosa wound infections. This novel model may be a useful tool in the investigation of bacterial pathogenesis and the development of new therapies for chronic P. aeruginosa wound infections.

Introduction

Pseudomonas aeruginosa (P. aeruginosa) is a Gram-negative rod-shaped bacterium with increasing relevance to human health and disease. It is responsible for extensive morbidity and mortality in nosocomial settings, particularly involving wound infections in immunocompromised patients1,2. The emergence of multidrug-resistant strains of this pathogen has provided further impetus for investigation into factors contributing to P. aeruginosa virulence, mechanisms of P. aeruginosa antibiotic resistance, and new methods for prevention and treatment of this deadly infection

Access restricted. Please log in or start a trial to view this content.

Protocol

All methods described here have been approved by the Institutional Animal Care and Use Committee (IACUC) at Stanford University.

1. Preparation and growth of bacteria

  1. Conduct all work with P. aeruginosa and animals with BSL-2 precautions per the researcher's institutional biosafety committee and animal use committee guidelines. Do all steps described here involving P. aeruginosa, including mouse inoculation, in a biosafety cabinet.
  2. The luminescent PAO1:lux strain of P. aeruginosa is available from our lab by request. Streak PAO1, stored as frozen glycerol stock, on Lysogeny Broth (LB) aga....

Access restricted. Please log in or start a trial to view this content.

Results

Using a luminescent strain of PAO1 with a plasmid encoding the luxABCDE reporter system (PAO1:lux), we performed excisional wounding on mice, inoculated these wounds with planktonic P. aeruginosa 24 h later, and measured bacterial burden over time (Figure 1 and Figure 2). A representative image obtained using an imaging optical system demonstrates that this model results in detectable luminescence (F.......

Access restricted. Please log in or start a trial to view this content.

Discussion

We have developed a novel delayed inoculation P. aeruginosa wound infection model. The strategy of delaying inoculation with bacteria until 24 h after excisional wounding enables the evaluation of wound infections over a 1-week timeframe. By using a luminescent strain of P. aeruginosa, it is possible to track infection progression throughout the infection course. The longer course of infection compared to other P. aeruginosa infection models will allow new opportunities for studying host-pathog.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have no competing financial interests to disclose.

Acknowledgements

The pUT-Tn5-EM7-lux-Km1 luminescent construct vector was a gracious gift from J. Hardy. Schematics were created with BioRender.com. We thank the lab of G. Gurtner for their advice on the wound infection model. We also thank T. Doyle from the Stanford Center for Innovation in In Vivo Imaging for his technical expertise. This work was supported by grants R21AI133370, R21AI133240, R01AI12492093, and grants from Stanford SPARK, the Falk Medical Research Trust and the Cystic Fibrosis Foundation (CFF) to P.L.B. C.R.D was supported by T32AI007502. A Gabilan Stanford Graduate Fellowship for Science and Engineering and a Lubert Stryer Bio-X Stanford Interdisciplinary ....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
0.9% Sodium Chloride injectionHospira2484457
18 G x 1 sterile needleBD305195
25 G x 1 1/5 sterile needleBD305127
Alcohol swabBD326895
Aura Imaging SoftwareSpectral Instruments Imagingn/a
BetadinePurdue Frederick Company19-065534
Buprenorphine SR LABZoopharmn/a
C57BL/6J male miceThe Jackson Laboratory000664
Disposable biopsy punch, 6mmIntegra33-36
Fine scissors - Tungsten CarbideFine Science Tools14568-09
Glass Bead Dry SterilizerHarvard Apparatus61-0183
Granulated AgarFisher BioReagentsBP9744
Heating PadMilliard804879481218
Insulin syringe with 28 G needleBD329461
Lago X Imaging SystemSpectral Instruments Imagingn/a
LB brothFisher BioReagentsBP1426
Leur-Lok 1 mL syringeBD309628
Mini Arco Animal TrimmerWahl Professional919152
Nair Hair Removal Lotion with Baby OilChurch and Dwightn/aAvailable at any pharmacy
Octagon ForcepsFine Science Tools11041-08
Petri dishFalcon351029
Phosphate Buffered Saline (PBS) 1xCorning21-040-CV
Press and Seal Cling WrapGladn/a
SafetyGlide Insulin syringe with 30 G needleBD305934
Safetyglide Insulin syringe, 1/2 mL, 30 G x 5/16 TWBD305934
ScaleOhaus Scout ProSP202
Supplical Nutritional SupplementHenry Schein Animal Health29908
Tegaderm, 6 cm x 7 cm3M1624W

References

  1. Sen, C. K., et al. Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair and Regeneration. 17 (6), 763-771 (2009).
  2. Serra, R., et al. Chronic....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Bioluminescence ImagingColony CountingFull Thickness WoundingBacterial BurdenChronic Infection ModelHost Pathogen InteractionsBSL-2 Safety